A Major Trial Just Found a New Treatment Option for Half…

A Major Trial Just Found a New Treatment Option for Half of All Chronic Kidney Disease Patients Worldwide Chronic kidney disease affects an estimated 800 million adults globally. Yet more than half of these patients, those without diabetes, have historically had very limited treatment options beyond standard blood pressure medications. A major international trial published in the New England Journal of Medicine may finally be changing that. The FIND CKD study enrolled 1,584 adults with chronic kidney disease, all without diabetes, all showing impaired kidney function along with protein in their urine, an important early warning sign of ongoing kidney damage. Participants were followed for just over three years, randomly assigned to receive either finerenone or a placebo, alongside their existing standard treatment with ACE inhibitors or angiotensin receptor blockers. Patients on f